Pyridoxamine protects proteins from damage by hypohalous acids in vitro and in vivo
Hartman Madu1, Josh Avance1, Sergei Chetyrkin1
1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Abstract:
Diabetes is characterized, in part, by activation of toxic oxidative and glycoxidative pathways that are triggered by persistent hyperglycemia and contribute to diabetic complications. Inhibition of these pathways may benefit diabetic patients by delaying the onset of complications. One such inhibitor, pyridoxamine (PM), had shown promise in clinical trials. However, the mechanism of PM action in vivo is not well understood. We have previously reported that hypohalous acids can cause disruption of the structure and function of renal collagen IV in experimental diabetes (K.L. Brown et al., Diabetes 64:2242-2253, 2015). In the present study, we demonstrate that PM can protect protein functionality from hypochlorous and hypobromous acid-derived damage via a rapid direct reaction with and detoxification of these hypohalous acids. We further demonstrate that PM treatment can ameliorate specific hypohalous acid-derived structural and functional damage to the renal collagen IV network in a diabetic animal model. These findings suggest a new mechanism of PM action in diabetes, namely sequestration of hypohalous acids, which may contribute to known therapeutic effects of PM in human diabetic nephropathy.
Insights
Pyridoxamine (PM) protects against diabetic kidney damage by neutralizing harmful hypohalous acids. This action, a novel mechanism, may explain PM
Area of Science:
- Biochemistry
- Nephrology
- Endocrinology
Background:
- Diabetes mellitus involves oxidative and glycoxidative stress, contributing to complications.
- Pyridoxamine (PM) shows therapeutic promise for diabetes, but its in vivo mechanism is unclear.
- Renal collagen IV is vulnerable to damage from hypohalous acids in diabetes.
Purpose of the Study:
- To elucidate the in vivo mechanism of pyridoxamine (PM) in diabetic nephropathy.
- To investigate PM's protective effects against hypohalous acid-induced damage.
Main Methods:
- Assessed PM's reaction with hypochlorous and hypobromous acids in vitro.
- Evaluated PM's ability to protect protein functionality from oxidative damage.
- Examined PM's effects on renal collagen IV structure and function in a diabetic animal model.
Main Results:
- Pyridoxamine (PM) directly reacts with and detoxifies hypohalous acids.
- PM protects protein functionality from damage caused by hypohalous acids.
- PM treatment ameliorates hypohalous acid-induced damage to renal collagen IV in diabetic rats.
Conclusions:
- Pyridoxamine (PM) acts by sequestering hypohalous acids, a novel mechanism in diabetes.
- This sequestration may underlie PM's therapeutic benefits in diabetic nephropathy.
- PM offers a potential strategy to mitigate diabetic complications via direct detoxification.
More Related Videos
08:01LERLIC-MS/MS for In-depth Characterization and Quantification of Glutamine and Asparagine Deamidation in Shotgun Proteomics
Published on: April 9, 2017
11:49Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
Published on: August 28, 2021
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
What are Proteins?
Protein Denaturation
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Physical Properties of Amines
Bioactivation and Tissue Toxicity
